JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.72B |
| 2 |
Amazon
AMZN
|
+$2.99B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.6B |
| 4 |
Mastercard
MA
|
+$1.47B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.62B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.93B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.95% |
| 2 | Healthcare | 10.56% |
| 3 | Financials | 9.04% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Photronics
PLAB
$1.97B
| $16.3M | ﹤0.01% |
806,046
-15,457
| -2% | -$361K |
|
1802
Spire
SR
$4.9B
| $16.3M | ﹤0.01% |
287,796
-29,691
| -9% | -$1.8M |
|
1803
Benchmark Electronics
BHE
$2.89B
| $16.3M | ﹤0.01% |
670,474
+19,037
| +3% | +$483K |
|
1804
Palomar
PLMR
$3.37B
| $16.3M | ﹤0.01% |
320,435
+203,917
| +175% | +$11.2M |
|
1805
VanEck Pharmaceutical ETF
PPH
$991M
| $16.2M | ﹤0.01% |
203,189
+150,365
| +285% | +$12.1M |
|
1806
Jones Lang LaSalle
JLL
$17B
| $16.2M | ﹤0.01% |
114,794
-32,382
| -22% | -$5.29M |
|
1807
Eastern Bankshares
EBC
$5.37B
| $16.2M | ﹤0.01% |
1,289,980
-153,397
| -11% | -$2.06M |
|
1808
MillerKnoll
MLKN
$1.62B
| $16.2M | ﹤0.01% |
660,824
-133,249
| -17% | -$2.49M |
|
1809
EPR Properties
EPR
$4.73B
| $16.1M | ﹤0.01% |
388,259
+77,185
| +25% | +$3.4M |
|
1810
Commault Systems
CVLT
$6.26B
| $16.1M | ﹤0.01% |
238,486
-25,446
| -10% | -$1.8M |
|
1811
StoneX
SNEX
$8.05B
| $16.1M | ﹤0.01% |
841,165
-41,279
| -5% | -$758K |
|
1812
B2Gold
BTG
$6.7B
| $16.1M | ﹤0.01% |
5,567,501
-355,197
| -6% | -$1.16M |
|
1813
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.4B
| $16.1M | ﹤0.01% |
252,903
+17,102
| +7% | +$1.14M |
|
1814
PUT
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
| $16M | ﹤0.01% |
725,000
+656,900
| +965% | +$27M |
|
1815
Beam Therapeutics
BEAM
$2.74B
| $15.9M | ﹤0.01% |
662,555
-45,125
| -6% | -$1.21M |
|
1816
John Wiley & Sons Class A
WLY
$2.63B
| $15.9M | ﹤0.01% |
428,034
+53,168
| +14% | +$1.89M |
|
1817
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.43B
| $15.9M | ﹤0.01% |
404,647
-5,576
| -1% | -$230K |
|
1818
DHT Holdings
DHT
$3.09B
| $15.8M | ﹤0.01% |
1,537,187
+446,952
| +41% | +$4.18M |
|
1819
Vishay Intertechnology
VSH
$5.11B
| $15.7M | ﹤0.01% |
636,833
+419
| +0.1% | +$11.3K |
|
1820
MoonLake Immunotherapeutics
MLTX
$1.4B
| $15.7M | ﹤0.01% |
275,598
-22,580
| -8% | -$1.25M |
|
|
PLYM
1821
DELISTED
Plymouth Industrial REIT
PLYM
| $15.7M | ﹤0.01% |
748,842
+200,361
| +37% | +$4.51M |
|
1822
Mattel
MAT
$4.25B
| $15.7M | ﹤0.01% |
711,321
-70,891
| -9% | -$1.51M |
|
1823
Blue Owl Capital
OBDC
$5.87B
| $15.7M | ﹤0.01% |
1,129,984
+735,568
| +186% | +$10.2M |
|
1824
CALL
Union Pacific
UNP
$177B
| $15.6M | ﹤0.01% |
76,800
+58,000
| +309% | +$12.6M |
|
1825
Rocket Pharmaceuticals
RCKT
$367M
| $15.6M | ﹤0.01% |
762,885
-53,409
| -7% | -$971K |
|
Similar funds
JP Morgan Chase's Q3 2023 Portfolio in Review
As of Q3 2023, JP Morgan Chase held 7,912 positions worth $906B, down 1.5% from $920B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
JP Morgan Chase's Q3 2023 filing shows 1,013 new, 2,454 increased, 3,092 reduced and 490 closed positions. Its largest new stake was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.62B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2023 buy was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M.
- JP Morgan Chase added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $3.72B increase.
- JP Morgan Chase's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.62B.
- JP Morgan Chase fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $314M.
- JP Morgan Chase's ten largest holdings make up 19% of its $906B portfolio in Q3 2023.
- JP Morgan Chase opened 1,013 new positions and closed 490 in Q3 2023.
- JP Morgan Chase's portfolio value fell 1.5% quarter-over-quarter to $906B.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.